-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
4-[1-[(2S)-2-Aminopropyl]-1H-pyrazol-3-yl]-2-chlorobenzonitrile, also known as ACB-301 or Gilotrif, is a compound that has been widely studied for its potential use in the treatment of various types of cancer.
However, this compound is not only limited to oncology applications but also has promising applications in the chemical industry.
One of the most significant applications of ACB-301 in the chemical industry is its use as a building block for the synthesis of novel drugs, dyes, and other chemicals.
As a building block, ACB-301 can be used to create a wide variety of compounds with specific properties, such as improved solubility, improved bioavailability, or improved efficacy.
The most promising applications of ACB-301 in the chemical industry are in the field of medicinal chemistry.
This compound is a potent inhibitor of several enzymes, including tyrosine kinases, which are involved in cell proliferation, differentiation, and survival.
As such, ACB-301 has the potential to be used as a foundation for the development of novel drugs that target these enzymes.
One of the most promising applications of ACB-301 in medicinal chemistry is in the development of new cancer therapies.
Due to its ability to inhibit tyrosine kinases, ACB-301 has the potential to be used as a treatment for a variety of cancers, including breast cancer, lung cancer, and colon cancer.
In addition, ACB-301 has been shown to have a high degree of selectivity for certain cancer cell lines, which could lead to a reduction in side effects for patients.
In addition to its use in cancer therapy, ACB-301 also has the potential to be used in the development of new drugs for the treatment of other diseases, such as inflammatory diseases and viral infections.
The compound's ability to inhibit tyrosine kinases makes it a promising candidate for the treatment of autoimmune diseases, such as rheumatoid arthritis, and viral infections, such as HIV and Hepatitis C.
ACB-301 also has the potential to be used as a building block for the synthesis of novel dyes, which can be used in a variety of applications, such as in textiles, plastics, and printing inks.
This compound can be used to create dyes with specific colors, improved solubility, and improved resistance to fading.
In addition to its use as a building block for the synthesis of novel chemicals, ACB-301 can also be used as a catalyst for the polymerization of various monomers.
This compound's ability to act as a catalyst can lead to the development of new polymers with specific properties, such as improved strength or flexibility.
Overall, the applications of ACB-301 in the chemical industry are vast and varied.
The compound's ability to act as a building block for the synthesis of novel drugs, dyes, and other chemicals, as well as its use as a catalyst for the polymerization of various monomers, make it a promising candidate for a wide range of applications in the chemical industry.
However, it is important to note that more research is needed to fully understand the potential of ACB-301 and to identify its best uses in the chemical industry.